Analysis of a cancer dormancy model and control of immuno-therapy
-
Received:
01 July 2014
Accepted:
29 June 2018
Published:
01 June 2015
-
-
MSC :
Primary: 92C50, 93C10; Secondary: 93D05.
-
-
The goal of this paper is to analyze a model of cancer-immune system interactions from [16], and to show how the introduction of control in this model can dramatically improve the hypothetical patient response and in effect prevent the cancer from growing. We examine all the equilibrium points of the model and classify them according to their stability properties. We identify an equilibrium point corresponding to a survivable amount of cancer cells which are exactly balanced by the immune response. This situation corresponds to cancer dormancy. By using Lyapunov stability theory we estimate the region of attraction of this equilibrium and propose two control laws which are able to stabilize the system effectively, improving the results of [16]. Ultimately, the analysis presented in this paper reveals that a slower, continuous introduction of antibodies over a short time scale, as opposed to mere inoculation, may lead to more efficient and safer treatments.
Citation: Ben Sheller, Domenico D'Alessandro. Analysis of a cancer dormancy model and control of immuno-therapy[J]. Mathematical Biosciences and Engineering, 2015, 12(5): 1037-1053. doi: 10.3934/mbe.2015.12.1037
-
Abstract
The goal of this paper is to analyze a model of cancer-immune system interactions from [16], and to show how the introduction of control in this model can dramatically improve the hypothetical patient response and in effect prevent the cancer from growing. We examine all the equilibrium points of the model and classify them according to their stability properties. We identify an equilibrium point corresponding to a survivable amount of cancer cells which are exactly balanced by the immune response. This situation corresponds to cancer dormancy. By using Lyapunov stability theory we estimate the region of attraction of this equilibrium and propose two control laws which are able to stabilize the system effectively, improving the results of [16]. Ultimately, the analysis presented in this paper reveals that a slower, continuous introduction of antibodies over a short time scale, as opposed to mere inoculation, may lead to more efficient and safer treatments.
References
[1]
|
Cancer Research, 73 (2013), 583-594.
|
[2]
|
Physica D, 208 (2005), 220-235.
|
[3]
|
Annu. Rev. Immunol., 22 (2004), 329-360.
|
[4]
|
Bull. Math. Biol., 73 (2011), 2-32.
|
[5]
|
Nature, 440 (2006), 1222-1226.
|
[6]
|
IEEE Transactions on Automatic Control, 30 (1985), 747-755.
|
[7]
|
Springer Verlag, Heidelberg-Berlin, 1967.
|
[8]
|
Prentice-Hall Information and System Sciences Series. Prentice-Hall, Inc., Englewood Cliffs, N.J., 1980.
|
[9]
|
John Wiley and Sons, 1995.
|
[10]
|
Cybern. syst. Anal, 23 (1988), 556-564.
|
[11]
|
Bull. Math. Biol, 56 (1994), 295-321.
|
[12]
|
Discrete and Continuous Dynamical Systems, Series B, 18 (2013), 1031-1051.
|
[13]
|
Journal of Mathematical Biology, 64 (2012), 557-577.
|
[14]
|
J. of the National Cancer Institute, 58 (1977), 1735-1741.
|
[15]
|
Cancer Research, 48 (1988), 7067-7071.
|
[16]
|
Leukemia and Lymphoma, 46 (2005), 313-327.
|
[17]
|
PNAS, 100 (2003), 8372-8377.
|
[18]
|
SIAM J. Control Optim., 48 (2010), 4377-4394.
|
[19]
|
Prentice-Hall, Advanced Reference Series (Engineering), 1989.
|
[20]
|
Nature Reviews Cancer, 12 (2012), 278-287.
|
[21]
|
Biophysics, 24 (1980), 917-923.
|
[22]
|
IPSJ Trans Math Model Appl., 47 (2006), 61-67.
|
[23]
|
Automatica, 21 (1985), 69-80.
|
[24]
|
Systems Biology of Tumor Dormancy, Springer, New York, 2013.
|
[25]
|
Israel Jerusalem Academic Press, 1962.
|
[26]
|
the Netherlands, Noordhoff, 1964.
|
[27]
|
January 7-10, 2013.
|
-
-
-
-